Hybrid closed‐loop glucose control with faster insulin aspart compared with standard insulin aspart in adults with type 1 diabetes: A double‐blind, multicentre, multinational, randomized, crossover study-Reference-Cited by-同舟云学术

Hybrid closed‐loop glucose control with faster insulin aspart compared with standard insulin aspart in adults with type 1 diabetes: A double‐blind, multicentre, multinational, randomized, crossover study

Published:2021-03-08 Issue:6 Volume:23 Page:1389-1396
ISSN:1462-8902
Container-title:Diabetes, Obesity and Metabolism
language:en
Short-container-title:Diabetes Obes Metab

Author:

Boughton Charlotte K.¹²^ORCID,Hartnell Sara²,Thabit Hood³⁴,Poettler Tina⁵,Herzig David⁶^ORCID,Wilinska Malgorzata E.¹,Ashcroft Nicole L.¹,Sibayan Judy⁷,Cohen Nathan⁷,Calhoun Peter⁷^ORCID,Bally Lia⁶^ORCID,Mader Julia K.⁵,Evans Mark¹²^ORCID,Leelarathna Lalantha³⁴,Hovorka Roman¹

Affiliation:

1. Wellcome Trust‐MRC Institute of Metabolic Science, Addenbrooke's Hospital Cambridge UK

2. Wolfson Diabetes and Endocrine Clinic Cambridge University Hospitals NHS Foundation Trust Cambridge UK

3. Diabetes, Endocrinology and Metabolism Centre Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre Manchester UK

4. Division of Diabetes, Endocrinology and Gastroenterology, Faculty of Biology, Medicine and Health University of Manchester Manchester UK

5. Division of Endocrinology and Diabetology, Department of Internal Medicine Medical University of Graz Graz Austria

6. Department of Diabetes, Endocrinology, Clinical Nutrition and Metabolism Inselspital, Bern University Hospital Bern Switzerland

7. Jaeb Center for Health Research Tampa Florida USA

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/dom.14355

Reference14 articles.

1. Artificial pancreas treatment for outpatients with type 1 diabetes: systematic review and meta-analysis

2. Six-Month Randomized, Multicenter Trial of Closed-Loop Control in Type 1 Diabetes

3. Closed-loop insulin delivery in suboptimally controlled type 1 diabetes: a multicentre, 12-week randomised trial

4. Faster insulin action is associated with improved glycaemic outcomes during closed-loop insulin delivery and sensor-augmented pump therapy in adults with type 1 diabetes

5. A Pooled Analysis of Clinical Pharmacology Trials Investigating the Pharmacokinetic and Pharmacodynamic Characteristics of Fast-Acting Insulin Aspart in Adults with Type 1 Diabetes

Cited by 62 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multicenter Evaluation of Ultra-Rapid Lispro Insulin with Control-IQ Technology in Adults, Adolescents, and Children with Type 1 Diabetes;Diabetes Technology & Therapeutics;2024-09-01

2. Postprandial Glucose Excursions with Ultra-Rapid Insulin Analogs in Hybrid Closed-Loop Therapy for Adults with Type 1 Diabetes;Diabetes Technology & Therapeutics;2024-07-01

3. Analogues ultra-rapides de l’insuline et délivrance automatisée de l’insuline, un réel pas en avant ?;Médecine des Maladies Métaboliques;2024-06

4. Actualisation de la prise de position des experts français sur l’insulinothérapie automatisée en boucle fermée;Médecine des Maladies Métaboliques;2024-06

5. The role of automated insulin delivery technology in diabetes;Diabetologia;2024-05-13